dd-cfDNA Significantly Improves Rejection Yield in Kidney Transplant Biopsies

By afschroeder • August 10, 2025

Bromberg JS, Brennan DC, Taber DJ, Cooper M, Anand S, Akalin E, Huang E, Klein JA, Glehn-Ponsirenas R, Rogers J, Chuang P, Kothari AS, Shen L, Woodward RN, Kumar D, Wojciechowski D, Mandelbrot D, Costa N, Bu L, Weir MR; KOAR investigators. dd-cfDNA Significantly Improves Rejection Yield in Kidney Transplant Biopsies. Am J Transplant. 2025 Aug 6:S1600-6135(25)02875-8. doi: 10.1016/j.ajt.2025.07.2484. Epub ahead of print. PMID: 40780562.

Tags: Biopsy yield, clinical utility of dd-cfDNA, dd-cfDNA, donor derived cell free DNA, KOAR (Kidney allograft Outcomes Allosure Registry). NCT03326076, Nephrology, post-kidney transplant biopsy, Publications, Rejection yield, sub-clinical rejection, surveillance biopsy

Declining Serum Albumin With Stable Body Mass Index: A Mortality Indicator in Predialysis Chronic Kidney Disease

Sarav M, Shrestha P, Naseer A, Thomas F, Sumida K, Kalantar-Zadeh K, Kovesdy CP. Declining Serum Albumin With Stable Body Mass Index: A Mortality Indicator[...]

Trimethylamine- N-Oxide Affects Cell Type-Specific Pathways and Networks in Mouse Aorta to Promote Atherosclerotic Plaque Vulnerability

Cheng J, Cheng M, Sinha S, Cely I, Gladkikh S, Han MT, Zhang G, Zhou Z, Chugh R, Ahn IS, Diamante G, Wang YC, Wang[...]

Efficacy of Acthar gel and Tacrolimus in DNA-JB9 Positive Fibrillary Glomerulopathy

Tumlin JA, Podoll A, Kopyt N, Rovin B, Lafayette R, Bomback A, Glassock R, Whitson J, Press A, Appel GB. Efficacy of Acthar gel and[...]